Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Eos SENOLYTIX Logo
Eos SENOLYTIX Growth Score
77
CB Rank
191977
Heat Score
65
Eos SENOLYTIX is a longevity biotech company developing therapeutics to target aging mechanisms.
Private Florida, New York, United States11-50 eossenolytix.com
Biotechnology
Life Science
Medical
Therapeutics
Overview

Eos SENOLYTIX
Growth Score
77
Heat Score
65

Growth Score77
-6 pts
in past quarter
Heat Score 65
43 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Eos SENOLYTIX

CB Rank
191977
Eos SENOLYTIX is a longevity biotech company developing therapeutics to target aging mechanisms.
Private Florida, New York, United States11-50 eossenolytix.com
Biotechnology
Life Science
Medical
Therapeutics

Details

Legal Name Eos SENOLYTIX, Inc.
Operating Status Active
Company Type For Profit
Predictions & Insights

Growth Insight

See this Growth Insight
Eos SENOLYTIX is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

Geropeptides
Therapeutic peptides targeting mitochondrial membrane potential to eliminate senescent cells and improve mitochondrial function in aging cells.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Contacts 1
News

News and Press

News•Jun 5, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 4, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 22, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 15, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

212

Active Website Tech Count

9Eos SENOLYTIX is actively using 9 technologies for its website, according to BuiltWith. These include DNSSEC, Content Delivery Network, and  Amazon.
Sub-Organizations
Frequently Asked Questions

Where is Eos SENOLYTIX's headquarters? Eos SENOLYTIX is located in Florida, New York, United States.Who are Eos SENOLYTIX's competitors? Alternatives and possible competitors to Eos SENOLYTIX may include BioAge Labs, Stealth BioTherapeutics, and  UNITY Biotechnology.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(250d0b0 1)
|